Provexis to exhibit Fruitflow later this year

9th Sep 2010 16:23

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health.The marketing strategy for Fruitflow is now being finalised and the technology will feature at some major trade exhibitions later in 2010. In parallel, the company's strategic partner, DSM Nutrition, has already entered into commercial discussions with major brand owners.The board has extended the trial of its Crohn's disease technology into two new centres and these will be fully operational by October 2010. This extension has been undertaken in order to bring a successful conclusion to the trials in 2011, after which a commercial partner for the technology will be sought.The company also plans to commence and complete two further clinical trials in 2011, one with the Institute of Food Research for reduction of cardiovascular inflammation, the second with the University of Liverpool for treatment of the hospital superbug c.difficile.The company, sitting on a £6.4m cash pile, intends to strengthen the company's technology, either through international developments or through acquisitions, or both.